Table 2.
Virus |
No. of specimens |
Performance of the GeXP assay |
||||||
---|---|---|---|---|---|---|---|---|
GeXP + aRVP + a | GeXP + RVP - | GeXP- RVP + | GeXP-aRVP -a | Sensitivity % | Specificity % | PPVa% | NPVa% | |
FluA |
5 |
0 |
0 |
121 |
100 |
100 |
100 |
100 |
sH1N1b |
3 |
0 |
0 |
123 |
100 |
100 |
100 |
100 |
FluB |
1 |
0 |
0 |
125 |
100 |
100 |
100 |
100 |
PIV1 |
1 |
0 |
0 |
125 |
100 |
100 |
100 |
100 |
PIV2 |
1 |
0 |
0 |
125 |
100 |
100 |
100 |
100 |
PIV3 |
21 |
3d |
0 |
102 |
100 |
97.14 |
87.50 |
100 |
HRVc |
68 |
6 |
3 |
49 |
95.77 |
89.09 |
91.89 |
94.23 |
HMPV |
8 |
0 |
2 |
116 |
80.00 |
100 |
100 |
98.31 |
Adv |
9 |
0 |
1 |
116 |
90.00 |
100 |
100 |
99.15 |
CoV NL63 |
1 |
0 |
0 |
125 |
100 |
100 |
100 |
100 |
CoV OC43 |
12 |
0 |
0 |
114 |
100 |
100 |
100 |
100 |
CoV 229E |
2 |
0 |
0 |
124 |
100 |
100 |
100 |
100 |
CoV HKU1 |
4 |
0 |
0 |
122 |
100 |
100 |
100 |
100 |
RSVAb |
2 |
0 |
0 |
124 |
100 |
100 |
100 |
100 |
RSVBb |
46 |
0 |
3 |
77 |
93.88 |
100 |
100 |
96.25 |
HBoV | 15 | 0 | 4 | 107 | 78.95 | 100 | 100 | 96.40 |
a The numbers of positive and negative specimens detected by the GeXP assay are indicated as GeXP + and GeXP -, respectively, and the numbers of positive and negative specimens detected by the RVP Fast assay are indicated as RVP + and RVP -, respectively. The sensitivity (True positives, TP), specificity (True negatives, TN), PPV (TP/TP + false positives), and NPV (TN/TN + false negatives) for each target are calculated using the RVP Fast assay as the reference for comparison.
b The RVP Fast assay was able to subtype the FluA and RSV positive specimens.
c The RVP Fast assay was not able to distinguish rhinovirus from enterovirus, so ‘HRV’ positive detected by the RVP Fast assay could be HRV or enterovirus. All of the specimens positive for HRV detected by the GeXP assay were confirmed by sequencing as true positives.
d All of the additional PIV3 detected only by the GeXP assay were confirmed by sequencing as true positives.